logo

Urogen Pharma Ltd. (URGN)



Trade URGN now with
  Date
  Headline
2/14/2018 8:05:00 AM UroGen Pharma Appoints Stephen Mullennix As COO
11/27/2017 8:44:54 AM UroGen Pharma Reports Oral Presentation At Society Of Urologic Oncology Annual Meeting
11/14/2017 7:13:44 AM UroGen Pharma Q3 Net Loss Of $0.3 Mln Or $0.02/shr Vs. Loss $8.0 Mln Or $3.73/shr Prior Year
11/6/2017 8:36:12 AM UroGen Says First Patient Enrolled In Allergan Phase 2 Clinical Trial Of RTGel In Combination With BOTOX
10/26/2017 8:52:50 AM UroGen Pharma Appoints Jeffrey Bova As VP Of Commercial And James Ottinger As VP Of Regulatory Affairs
9/6/2017 8:35:18 AM UroGen Pharma Appoints Paul Chu VP Of Business Development
8/29/2017 8:33:29 AM UroGen Pharma Gets FDA Fast Track Designation For MitoGelfor The Treatment Of Upper Tract Urothelial Carcinoma
5/16/2017 8:17:28 AM UroGen Pharma Appoints Fred Cohen To Board Of Directors